Idera Pharmaceuticals, Inc.

IDRA · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$12,044$32,545$33,229$40,019
Short-Term Investments$0$0$4,499$2,774
Receivables$4,208$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,611$1,493$3,627$3,475
Total Curr. Assets$17,863$34,038$41,355$46,268
Property Plant & Equip (Net)$544$756$974$1,151
Goodwill$11,100$0$0$0
Intangibles$71,600$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$70$70$70
Total NC Assets$83,244$826$1,044$1,221
Other Assets$0$0$0$0
Total Assets$101,107$34,864$42,399$47,489
Liabilities
Payables$5,200$565$329$457
Short-Term Debt$234$209$191$163
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$15,989$4,088$6,507$53,897
Total Curr. Liab.$21,423$4,862$7,027$54,517
LT Debt$326$549$758$899
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$3,283$0$0$0
Other NC Liab.$37,141$0$125,786$3,241
Total NC Liab.$40,750$549$126,544$4,140
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$62,173$5,411$133,571$58,657
Equity
Pref Stock$34,300$0$0$0
Common Stock$4$53$38$30
Retained Earnings-$758,821-$735,461-$833,552-$720,890
AOCI-$21$0$0-$774
Other Equity$736,364$764,861$742,342$710,466
Total Equity$11,826$29,453-$91,172-$11,168
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$73,999$34,864$42,399$47,489
Net Debt-$11,484-$31,787-$32,280-$38,957